Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2024-06-13 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
第四届监事会第三十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of a supervisory board meeting resolution regarding the proposal to reappoint the auditing firm for the 2024 fiscal year. It includes details about the meeting date, attendance, agenda, and voting results. The document does not contain actual audit reports or financial statements but rather the decision to continue the auditor engagement. It references a separate announcement for the auditor reappointment. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about corporate governance and audit arrangements, not the audit report itself or an annual report.
2024-06-13 Chinese
高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the resignation of a senior management personnel, specifically the company secretary and board secretary, including details about the resignation date, reasons, and impact on the company. It does not contain financial data, audit information, or any report content. It is clearly an announcement about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2024-06-06 Chinese
第四届董事会第三十三次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 33rd meeting of the 4th Board of Directors of Beijing Kangle Weishi Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and compliance with legal and procedural requirements. The content focuses on board decisions, specifically about the approval of a subsidiary's investment in establishing a new company in Indonesia. There is no financial data, earnings information, or detailed report content. The document is clearly a Board/Management Information announcement regarding board meeting resolutions and decisions.
2024-05-19 Chinese
关于子公司对外投资设立印尼子公司的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Beijing Kangle Weishi Biotechnology Co., Ltd. regarding its subsidiary's external investment to establish a new subsidiary in Indonesia. It details the investment overview, decision-making process, investment object information, investment purpose, risks, and impact on the company. The document includes board meeting resolutions and approvals related to this investment. It does not contain financial statements or detailed financial performance data. It is a regulatory announcement about a capital investment and establishment of a subsidiary, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 2374 characters, which is short but contains substantive information about the investment, not just a brief notice or report publication announcement.
2024-05-19 Chinese
关于子公司申请银行综合授信暨公司提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a subsidiary's application for a bank comprehensive credit facility and the parent company's provision of a guarantee. It includes details about the guarantee amount, decision-making process, and financial data of the subsidiary. The document is relatively short (2250 characters) and focuses on a specific financing-related event rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis. The content aligns with updates on company financing activities and guarantees. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2024-04-25 Chinese
2024年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2024 年第一季度报告" which translates to "2024 First Quarter Report." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the quarter ending March 31, 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and management commentary on financial results and significant events during the quarter. It is unaudited, which is typical for interim reports. The length of the document (15,000 characters) and the presence of detailed financial data confirm it is a full interim/quarterly report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-04-25 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.